drugset / Trial / NCT00933634

Efficacy and Safety of Electrical Versus Pharmacological Cardioversion in Early Atrial Fibrillation

NCT00933634

Completed 247 enrolled Valduce Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

The optimal strategy to restore sinus rhythm in patients with atrial fibrillation (AF) of less than 48 hours' duration is still controversial. The investigators performed a controlled single-center trial to compare electrical and pharmacological (propafenone) cardioversion to restore the sinus rhythm in selected patients with acute atrial fibrillation.

Timeline

Start
2006-01
Primary completion
2008-11
Completion
2008-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator propafenone Unknown 2 mg/kg Intravenous

Indications